Literature DB >> 19118211

Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails.

Kyle R Legate1, Reinhard Fässler.   

Abstract

Cells recognize and respond to their extracellular environment through transmembrane receptors such as integrins, which physically connect the extracellular matrix to the cytoskeleton. Integrins provide the basis for the assembly of intracellular signaling platforms that link to the cytoskeleton and influence nearly every aspect of cell physiology; however, integrins possess no enzymatic or actin-binding activity of their own and thus rely on adaptor molecules, which bind to the short cytoplasmic tails of integrins, to mediate and regulate these functions. Many adaptors compete for relatively few binding sites on integrin tails, so regulatory mechanisms have evolved to reversibly control the spatial and temporal binding of specific adaptors. This Commentary discusses the adaptor proteins that bind directly to the tails of beta integrins and, using talin, tensin, filamin, 14-3-3 and integrin-linked kinase (ILK) as examples, describes the ways in which their binding is regulated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19118211     DOI: 10.1242/jcs.041624

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  169 in total

1.  Divalent cations regulate the folding and activation status of integrins during their intracellular trafficking.

Authors:  Shweta Tiwari; Janet A Askari; Martin J Humphries; Neil J Bulleid
Journal:  J Cell Sci       Date:  2011-04-21       Impact factor: 5.285

2.  Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.

Authors:  Cláudia Alessandra Andrade de Paula; Vivien Jane Coulson-Thomas; Joana Gasperazzo Ferreira; Paloma Korehisa Maza; Erika Suzuki; Adriana Miti Nakahata; Helena Bonciani Nader; Misako Uemura Sampaio; Maria Luiza V Oliva
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

3.  Integrins regulate microtubule nucleating activity of centrosome through mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signaling.

Authors:  Diane Colello; Shomita Mathew; Rachel Ward; Kevin Pumiglia; Susan E LaFlamme
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

4.  Subcellular localization of talin is regulated by inter-domain interactions.

Authors:  Asoka Banno; Benjamin T Goult; HoSup Lee; Neil Bate; David R Critchley; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2012-02-18       Impact factor: 5.157

5.  Identification, characterization, and epitope mapping of human monoclonal antibody J19 that specifically recognizes activated integrin α4β7.

Authors:  JunPeng Qi; Kun Zhang; Qiao Zhang; Yi Sun; Ting Fu; GuoHui Li; JianFeng Chen
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

6.  Tailored integrin-extracellular matrix interactions to direct human mesenchymal stem cell differentiation.

Authors:  Jessica Ellen Frith; Richard James Mills; James Edward Hudson; Justin John Cooper-White
Journal:  Stem Cells Dev       Date:  2012-05-31       Impact factor: 3.272

Review 7.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

8.  Modulation of integrin activation by an entropic spring in the {beta}-knee.

Authors:  Benoit J Smagghe; Po-Ssu Huang; Yih-En Andrew Ban; David Baker; Timothy A Springer
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 9.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

Review 10.  Integrins in Wound Healing.

Authors:  Leeni Koivisto; Jyrki Heino; Lari Häkkinen; Hannu Larjava
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.